March 27, 2017VIA SEDAR
To:All Applicable Commissions and Stock Exchanges
Dear Sirs:
Re: VANC Pharmaceuticals Inc. (the “Company”)
As per National Instrument 54-101 requirements, we advise the following with respect to the upcoming Meeting of Shareholders for the subject Company:
Issuer: | VANC Pharmaceuticals Inc. |
CUSIP: | 92143R204 |
ISIN: | CA92143R2046 |
Meeting Date: | July 27, 2017 |
Meeting Type: | Annual General and Special Meeting |
Record Date for Notice: | May 31, 2017 |
Record Date for Voting: | May 31, 2017 |
Beneficial Ownership Determination Date: | May 31, 2017 |
Class of Securities Entitled to Receive Notice: | Common |
Class of Securities Entitled to Vote: | Common |
Issuer sending proxy related materials directly to NOBO: | Yes |
Issuer paying for delivery to OBO: | No |
Meeting Location: | To be determined |
Notice and Access (NAA) Requirements: NAA for Beneficial Holders: NAA for Registered Holders: |
No No |
Yours truly,
VANC PHARMACEUTICALS INC.
Signed: “Eugene Beukman”
Eugene Beukman
Director and Corporate Secretary
